NASDAQ · Health care

SciSparc Ltd. (SPRC)

SciSparc Ltd. reported revenue of $1.3M in fiscal 2024, down 54.6% from a year earlier. It posted a net loss of $6.3M. At December 31, 2024 it held $1.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on August 19, 2026.

Price

$5.21

-3.34% on the day · September 25, 2026

52-week range $2.98 to $63.90

Market cap

$3M

Revenue (FY2024)

$1.3M

-54.6% year on year

Net margin

-481.2%

What SciSparc Ltd. does

SciSparc Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SPRC.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2024	$1.3M	-$7.3M	-$6.3M	$1.28	n/a
2023	$2.9M	-$6.8M	-$5.1M	$14.43	n/a
2022	$1.3M	-$8.3M	-$2.6M	$14.82	-$7.9M
2021	n/a	-$5.8M	-$5.8M	$73.58	-$5.1M
2020	n/a	-$3.3M	-$3.5M	$0.11	n/a
2019	n/a	-$4.1M	-$4.7M	$0.64	-$4.7M

Where SPRC ranks in Health care

Revenue$1.3M

#558 of 646 in Health care · Bottom 14%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What SciSparc Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 24, 2026
Foreign issuer update 6-K
September 2, 2026
Foreign issuer update 6-K
August 26, 2026
Foreign issuer update 6-K
August 24, 2026
Foreign issuer update 6-K
August 19, 2026
Form F-3/A filing F-3/A
August 19, 2026
Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2025
August 18, 2026
Foreign issuer update 6-K
August 12, 2026
Foreign issuer update 6-K
August 5, 2026
Foreign issuer update 6-K
July 31, 2026
Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 13, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SPRC

What does SciSparc Ltd. do?

SciSparc Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SPRC.

Is SciSparc Ltd. profitable?

No. In fiscal 2024 it reported a net loss of $6.3M on revenue of $1.3M.

How much revenue does SciSparc Ltd. make?

In fiscal 2024 SciSparc Ltd. reported revenue of $1.3M. That is 54.6% less than a year earlier.

When did SciSparc Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on August 19, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 24, 2026.

Similar companies

Compare SPRC with

Compare SPRC with any company

Follow SPRC

Get an email when SciSparc Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SPRC: get an email when it files

Where the numbers come from

Financial figures are the values SciSparc Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.